These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 11011809)
21. Treatment of deep vein thrombosis using low-molecular-weight heparins. Groce JB Am J Manag Care; 2001 Nov; 7(17 Suppl):S510-5; discussion S515-23. PubMed ID: 11732662 [TBL] [Abstract][Full Text] [Related]
22. Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism: a meta-analysis. Couturaud F; Julian JA; Kearon C Thromb Haemost; 2001 Oct; 86(4):980-4. PubMed ID: 11686355 [TBL] [Abstract][Full Text] [Related]
23. New-generation anticoagulants: the low molecular weight heparins. Hovanessian HC Ann Emerg Med; 1999 Dec; 34(6):768-79. PubMed ID: 10577408 [TBL] [Abstract][Full Text] [Related]
24. Low-molecular-weight heparins for the prevention and treatment of venous thromboembolism. Ornstein DL; Hong-Dice YG; Papini JR Mil Med; 2001 Jul; 166(7):593-601. PubMed ID: 11469031 [TBL] [Abstract][Full Text] [Related]
25. Subcutaneous unfractionated heparin compared with low-molecular-weight heparin for the initial treatment of venous thromboembolism. Bernardi E; Prandoni P Curr Opin Pulm Med; 2005 Sep; 11(5):363-7. PubMed ID: 16093806 [TBL] [Abstract][Full Text] [Related]
26. [Anticoagulation in patients with venous thromboembolism]. Rüfer A; Wuillemin WA Ther Umsch; 2003 Jan; 60(1):43-7. PubMed ID: 12638478 [TBL] [Abstract][Full Text] [Related]
27. [State of the art: low-molecular-weight heparin and beyond]. Cimminiello C; Casali G; Vitali L Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):61-5. PubMed ID: 11253343 [TBL] [Abstract][Full Text] [Related]
28. Low molecular weight heparins in the long-term treatment of venous thromboembolism. Liapis CD; Daskalopoulos ME; Daskalopoulou SE J Cardiovasc Surg (Torino); 2002 Aug; 43(4):495-500. PubMed ID: 12124561 [TBL] [Abstract][Full Text] [Related]
29. Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins? Agnelli G Haematologica; 1995; 80(2 Suppl):78-83. PubMed ID: 7628776 [No Abstract] [Full Text] [Related]
30. Management of venous thromboembolism: optimization by clinical trials. Turpie AG Haemostasis; 1996 Oct; 26 Suppl 4():220-6. PubMed ID: 8979127 [TBL] [Abstract][Full Text] [Related]
31. Tinzaparin in the treatment of venous thromboembolism. Pineo GF; Hull RD Expert Opin Pharmacother; 2003 Dec; 4(12):2355-62. PubMed ID: 14640933 [TBL] [Abstract][Full Text] [Related]
32. Treatment of venous thromboembolism. Eichinger S Wien Med Wochenschr; 2005 Jan; 155(1-2):7-10. PubMed ID: 15773736 [TBL] [Abstract][Full Text] [Related]
33. A randomized trial comparing 2 low-molecular-weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism. Wells PS; Anderson DR; Rodger MA; Forgie MA; Florack P; Touchie D; Morrow B; Gray L; O'Rourke K; Wells G; Kovacs J; Kovacs MJ Arch Intern Med; 2005 Apr; 165(7):733-8. PubMed ID: 15824291 [TBL] [Abstract][Full Text] [Related]
34. Low-molecular-weight heparin in the treatment of pulmonary embolism. Ageno W; Turpie AG Semin Vasc Surg; 2000 Sep; 13(3):189-93. PubMed ID: 11005462 [TBL] [Abstract][Full Text] [Related]
35. Low-molecular-weight heparins versus unfractionated heparin in the treatment of deep vein thrombosis and pulmonary embolism. Merli GJ Am J Phys Med Rehabil; 2000; 79(5 Suppl):S9-16. PubMed ID: 10994898 [TBL] [Abstract][Full Text] [Related]
36. Low-molecular-weight heparins: are they interchangeable? van der Heijden JF; Prins MH; Büller HR Haemostasis; 2000; 30 Suppl 2():148-57; discussion 146-7. PubMed ID: 11251361 [TBL] [Abstract][Full Text] [Related]
37. A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency. Dolovich LR; Ginsberg JS; Douketis JD; Holbrook AM; Cheah G Arch Intern Med; 2000 Jan; 160(2):181-8. PubMed ID: 10647756 [TBL] [Abstract][Full Text] [Related]
38. Tinzaparin sodium: a low-molecular-weight heparin. Neely JL; Carlson SS; Lenhart SE Am J Health Syst Pharm; 2002 Aug; 59(15):1426-36. PubMed ID: 12166042 [TBL] [Abstract][Full Text] [Related]
39. Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis. Leizorovicz A; Simonneau G; Decousus H; Boissel JP BMJ; 1994 Jul; 309(6950):299-304. PubMed ID: 8086867 [TBL] [Abstract][Full Text] [Related]